NCT00001720View on ClinicalTrials.gov

Treatment of Childhood Osteoporosis With Alendronate (Fosamax)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 1998

Study Completion Date

June 30, 2003

Conditions
Osteoporosis
Interventions
DRUG

Alendronate

Trial Locations (1)

20892

National Institute of Child Health and Human Development (NICHD), Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00001720 - Treatment of Childhood Osteoporosis With Alendronate (Fosamax) | Biotech Hunter | Biotech Hunter